Start Submission Become a Reviewer

Reading: Predictors and Management of Right Heart Failure after Left Ventricular Assist Device Implan...

Download

A- A+
Alt. Display

Review Articles

Predictors and Management of Right Heart Failure after Left Ventricular Assist Device Implantation

Authors:

Nadia Fida ,

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US
About Nadia
M.D.
X close

Matthias Loebe,

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US
About Matthias
M.D.
X close

Jerry D. Estep,

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US
About Jerry D.
M.D.
X close

Ashrith Guha

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US
About Ashrith
M.D., M.P.H.
X close

Abstract

Newer generation continuous-flow left ventricular assist devices (LVADs) have overall improved outcomes with lower incidences of right ventricular failure (RVF) than their pulsatile predecessors, yet RVF still occurs in 9% to 40% of LVAD recipients. Postimplant, RVF is associated with poor outcomes, end-organ dysfunction, high mortality, and reduced survival to transplant. Therefore, preoperative risk stratification, appropriate patient selection, and optimal timing of implant are of paramount importance. In this article, we review the definition, incidence, pathophysiology, and current risk prediction models for RVF and touch on the contemporary management of RVF perioperatively and post-LVAD implant.

How to Cite: 1. Fida N, Loebe M, Estep JD, Guha A. Predictors and Management of Right Heart Failure after Left Ventricular Assist Device Implantation. Methodist DeBakey Cardiovascular Journal. 2015;11(1):18-23. DOI: http://doi.org/10.14797/mdcj-11-1-18
4
Views
2
Downloads
Published on 01 Jan 2015.
Peer Reviewed

Downloads

  • PDF (EN)